KR102596697B1 - Cosmetic composition containing Orostachys japonicus extract as an active ingredient and method for manufacturing cosmetic composition - Google Patents
Cosmetic composition containing Orostachys japonicus extract as an active ingredient and method for manufacturing cosmetic composition Download PDFInfo
- Publication number
- KR102596697B1 KR102596697B1 KR1020210064717A KR20210064717A KR102596697B1 KR 102596697 B1 KR102596697 B1 KR 102596697B1 KR 1020210064717 A KR1020210064717 A KR 1020210064717A KR 20210064717 A KR20210064717 A KR 20210064717A KR 102596697 B1 KR102596697 B1 KR 102596697B1
- Authority
- KR
- South Korea
- Prior art keywords
- rock
- cosmetic composition
- extract
- brush
- harvested
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 239000000284 extract Substances 0.000 title claims abstract description 52
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 239000004480 active ingredient Substances 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 241000304370 Orostachys Species 0.000 title 1
- 239000011435 rock Substances 0.000 claims abstract description 39
- 235000013267 Pinus ponderosa Nutrition 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 17
- 238000007865 diluting Methods 0.000 claims abstract description 5
- 241000555277 Pinus ponderosa Species 0.000 claims abstract 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- 238000000605 extraction Methods 0.000 claims description 17
- 238000003306 harvesting Methods 0.000 claims description 10
- 229920001661 Chitosan Polymers 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 210000003491 skin Anatomy 0.000 abstract description 29
- 230000002087 whitening effect Effects 0.000 abstract description 15
- 230000001976 improved effect Effects 0.000 abstract description 14
- 230000003020 moisturizing effect Effects 0.000 abstract description 14
- 210000004927 skin cell Anatomy 0.000 abstract description 5
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 50
- 241001165529 Orostachys japonica Species 0.000 description 27
- 230000000694 effects Effects 0.000 description 24
- 239000000047 product Substances 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 239000004909 Moisturizer Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 230000001333 moisturizer Effects 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 102000016387 Pancreatic elastase Human genes 0.000 description 8
- 108010067372 Pancreatic elastase Proteins 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 102000029816 Collagenase Human genes 0.000 description 7
- 108060005980 Collagenase Proteins 0.000 description 7
- 230000004663 cell proliferation Effects 0.000 description 7
- 229960002424 collagenase Drugs 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 230000008099 melanin synthesis Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000037380 skin damage Effects 0.000 description 5
- 230000036560 skin regeneration Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000003809 water extraction Methods 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000020240 turmeric extract Nutrition 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- 241000245032 Trillium Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000008513 turmeric extract Substances 0.000 description 2
- 229940052016 turmeric extract Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ZLFQNOJSYZSINX-PVJKAEHXSA-N (2s)-2-[[(2s)-1-[2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-4-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]propanoic acid Chemical compound N([C@@H](CC(C)C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)C(=O)\C=C\C1=CC=CO1 ZLFQNOJSYZSINX-PVJKAEHXSA-N 0.000 description 1
- YMMPZCZOLKBHAP-IHPCNDPISA-N (2s)-2-[[(2s)-1-[2-[[2-[[(2s)-1-[2-(phenylmethoxycarbonylamino)acetyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)[C@H]1N(C(=O)CNC(=O)OCC=2C=CC=CC=2)CCC1 YMMPZCZOLKBHAP-IHPCNDPISA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 229940122858 Elastase inhibitor Drugs 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 231100000028 nontoxic concentration Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000009329 organic farming Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Abstract
본 발명은 바위솔 추출물을 유효성분으로 포함하는 화장품 조성물에 관한 것이다. 상기 화장품 조성물은 바위솔 모종을 식재하고, 키토산올리고당을 1:100 ~ 1:1,000의 중량비로 물에 희석한 후 수일 간격으로 엽면시비하여 재배 및 수확하고, 수확한 바위솔을 추출한 바위솔 추출물을 유효성분으로 함유하는 것을 특징으로 한다.
이러한 화장품 조성물은 종래의 바위솔 추출물보다 효과가 향상된 추출물을 유효성분으로 함유하여, 피부 미백, 피부 각질의 보습, 탄력, 재생 촉진하 여 촉촉함의 유지 및 당김, 건조 등을 해소하고 피부 미백 및 탄력을 증대시키는 효과가 있어, 항노화 화장품 조성물로서 매우 적합 유용하게 사용될 수 있다.The present invention relates to a cosmetic composition containing rock pine extract as an active ingredient. The cosmetic composition is grown and harvested by planting rock brush seedlings, diluting chitosan oligosaccharide in water at a weight ratio of 1:100 to 1:1,000, and then applying foliar application at intervals of several days, and using rock brush extract extracted from the harvested rock brush as an active ingredient. It is characterized by containing.
This cosmetic composition contains as an active ingredient an extract with improved effectiveness compared to the conventional rock pine extract, and promotes skin whitening, moisturizing, elasticity, and regeneration of dead skin cells, maintaining moisture, relieving tightness, dryness, etc., and improving skin whitening and elasticity. It has an enhancing effect, so it can be very suitable and useful as an anti-aging cosmetic composition.
Description
본 발명은 바위솔 추출물을 유효성분으로 포함하는 화장품 조성물에 관한 것 으로 보다 상세하게는 키토산올리고당을 이용하여 친환경 유기농 재배한 바위솔을 수확 시기별 및 추출 용매별 다양한 추출물을 제조하고 이를 유효성분으로 함유하 는 피부 미백, 보습 및 재생에 탁월한 항노화 화장품 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a rock pine extract as an active ingredient. More specifically, the present invention relates to a cosmetic composition containing a rock pine extract as an active ingredient. In more detail, various extracts of rock pine grown in eco-friendly organic farming using chitosan oligosaccharide are prepared according to the harvest time and extraction solvent and contained as an active ingredient. relates to an anti-aging cosmetic composition that is excellent for skin whitening, moisturizing and regeneration.
인간의 피부는 발생과정에서 외배엽과 중배엽에서 유래하며 우리 몸의 부위 에 따라서 그 두께의 차이를 나타낸다. 피부는 크게 두 층으로 외부에 노출되어 있 는 표피층과 바로 밑층인 진피층으로 구별되며, 마찰이 많은 손바닥이나 발바닥 층 은 다른 부위에 비하여 표피에 투명 층이 있어서 더 두껍다. 그리고 얼굴의 표피층 이 가장 얇은 층으로 되어 있고, 특히 입술은 그중에서도 표피층이 가장 얇다. 대 부분의 표피층의 가장 밖에 층에는 죽은 세포인 각질층으로 구성되며, 이는 외부 및 내부로부터 방어 기작에 관여한다.Human skin originates from the ectoderm and mesoderm during development, and its thickness varies depending on the part of our body. The skin is largely divided into two layers: the epidermis layer, which is exposed to the outside, and the dermis layer, which is the layer immediately below. The layers of the palms and soles, which experience a lot of friction, are thicker than other areas because they have a transparent layer on the epidermis. And the epidermis layer of the face is the thinnest, and the lips in particular have the thinnest epidermis layer. The outermost layer of most epidermis layers is composed of dead cells called the stratum corneum, which is involved in defense mechanisms from the outside and inside.
즉, 건강한 사람은 각질세포에 고농도의 자연 보습 인자가 많이 존재하여 피 부의 보습에 관련된 수분 보유 능력을 도와주며, 일부 아미노산은 수용성을 띄기 때문에 효과적으로 수분과 결합하여 피부가 건조되는 것을 억제한다고 보고하였 다(J. Invest. Dermatol. 54, 24-31, 1970).In other words, it has been reported that healthy people have a high concentration of natural moisturizing factors in keratinocytes, which helps the skin's ability to retain moisture related to moisturizing, and because some amino acids are water-soluble, they effectively bind with moisture and prevent skin from drying out. (J. Invest. Dermatol. 54, 24-31, 1970).
일반적으로 피부 노화는 자외선 노출로 피부 세포에서 생긴 사이토카인에 의한 염증 발현, 표피 바닥막의 손상, 피부색의 변화, 각종 의약품의 오남용, 피부건 조, 화학물의 노출 그리고 화장품의 사용 등에 의해 생성된다.In general, skin aging is caused by inflammation caused by cytokines produced in skin cells due to exposure to ultraviolet rays, damage to the epidermal basement membrane, changes in skin color, misuse of various medicines, dry skin, exposure to chemicals, and use of cosmetics.
활성산소는 자외선 및 호흡 등에 의해 유발되는 상기의 한 원인이 되며, 한 번 생성된 활성산소는 혈관 세포에도 영향을 미쳐 많은 문제를 야기하는 것으로 알 려졌다.Free radicals are one of the causes of the above-mentioned conditions caused by ultraviolet rays and respiration, and once generated, free radicals are known to affect blood vessel cells and cause many problems.
더불어 현대사회에서 인간의 피부는 각종 화합물에 노출될 가능성이 증가하 고, 생활환경의 변화에 따른 외부 환경오염에 노출 및 실생활에서 오는 개인적인 스트레스 및 노화에 따른 피부변화 등의 다양한 피부 트러블이 발생하는 빈도가 많아지고 있다.In addition, in modern society, human skin is more likely to be exposed to various chemical compounds, and various skin problems occur, such as exposure to external environmental pollution due to changes in living environment, personal stress from daily life, and skin changes due to aging. The frequency is increasing.
종전에는 상기의 피부 트러블을 해소하기 위한 방법의 하나로 보습제를 사용하였으며, 수분을 흡수하는 성질이 있는 보습제나 수분 증발을 방지하는 폐쇄 보습제를 사용하여 결국 각질층에서 수분 보유를 증가시키도록 하는 방식이 행해져 왔다. Previously, moisturizers were used as one of the methods to resolve the above-mentioned skin troubles. Moisturizers with moisture-absorbing properties or occlusive moisturizers that prevent moisture evaporation were used to ultimately increase moisture retention in the stratum corneum. come.
상기의 보습제로는 주로 글리세린, 폴리에틸렌글리콜, 1,3-부틸렌글리콜, 솔 비톨, 프로필렌글리콜, 2-피롤리돈-5-카르본산나트륨 등의 물질이 있으나, 피부에 도포 시 끈적임이 강하거나 눅진한 느낌이 드는 단점이 있다. The above moisturizers mainly include substances such as glycerin, polyethylene glycol, 1,3-butylene glycol, sorbitol, propylene glycol, and sodium 2-pyrrolidone-5-carboxylate, but when applied to the skin, they are not sticky or sticky. The downside is that it feels damp.
또한, 폐쇄 보습제로는 세라마이드 등의 지질 성분이나 필수 지방산 및 지질복합체 등이 사용되었으나(J. Invest. Dermatol. (5), 731-740, 1994), 유화 제형의 안정도를 유지하는데 어려움이 있어 투명한 젤 형태의 제품을 제조하는 데에는 부적합한 단점이 있다.In addition, lipid components such as ceramide, essential fatty acids, and lipid complexes have been used as occlusive moisturizers (J. Invest. Dermatol. (5), 731-740, 1994), but it is difficult to maintain the stability of the emulsion formulation, so it is not transparent. It has the disadvantage of being unsuitable for manufacturing gel-type products.
그러나 최근에는 상기의 각종 화학적 보습제나 폐쇄 보습제 대신에 천연물로 부터 추출된 보습제들이 탐색되고 있으며, 이들의 유효성분을 추출하는 기술이 발전하여 그 이용 가능성이 높아지고 있다. 이들 중 하나의 가능성 식물로서 바위솔이 급부상하고 있다.However, recently, moisturizers extracted from natural products are being explored instead of the various chemical moisturizers or occlusive moisturizers mentioned above, and technology for extracting their active ingredients has been developed, increasing their availability. As one of these potential plants, rock brush is rapidly emerging.
바위솔(Orostachys japonica)은 돌나물과에 속하는 약용식물로 현재는 식용 가능한 식품(2013년에 지정) 식물로서, 주로 한국의 산과 바위에서 자라는 다년생 초본 다육식물이다. 전초는 약 20~40cm 정도 자란다. 생육환경은 햇볕이 잘 드는 바위나 집 주변의 기와에서 자란다 하여 일명 ‘와송(瓦松)’이라고도 하며, 잎은 원줄기에 많이 붙어 있으며, 끝 부분은 가시처럼 날카롭다. 꽃은 흰색으로 줄기 아 랫부분에서부터 피며 점차 위쪽으로 올라간다. 가을(9월 중순부터)에 꽃대가 출현 하면 아래에서 위로 올라가면서 촘촘하던 잎들은 모두 줄기를 따라 올라가며 느슨해진다. 꽃이 피고 씨앗이 맺히면 잎은 고사하는 특징이 있다. 바위솔은 다육식물 로 습기가 많은 곳에서는 뿌리가 썩을 수 있어서 물 빠짐이 좋은 땅에서 잘 자란 다. Orostachys japonica is a medicinal plant belonging to the Crassulaceae family and is currently an edible food plant (designated in 2013). It is a perennial herbaceous succulent that mainly grows in the mountains and rocks of Korea. The outpost grows to about 20 to 40 cm. The growing environment is that it grows on sunny rocks or tiles around houses, so it is also called 'Wasong (瓦松)'. Many leaves are attached to the main stem, and the ends are sharp like thorns. The flowers are white and bloom from the bottom of the stem and gradually rise upward. When flower stalks appear in the fall (from mid-September), all the leaves, which were dense as they rise from the bottom to the top, move up along the stem and become loose. When flowers bloom and seeds set, the leaves die. Rock brush is a succulent plant. Its roots can rot in places with too much moisture, so it grows well in well-drained soil.
상술한 바위솔은 해열, 지혈, 소종, 이습(利濕) 등의 효능이 있다. 동의보감 에 의하면 적용질환은 학질과 간염, 습진, 이질설사, 치질, 악성종기, 화상 등의 치료에 쓴다. 종기에 붙이면 고름을 빨아내는 효과가 크다. 또한. 해독제로 벌레나 독사에 물린 상처에 붙인다. 최근에는 각종 연구에서 항암 성분이 있다고 알려졌 다.The above-mentioned rock brush has effects such as fever reduction, hemostasis, swelling, and healing. According to Donguibogam, it is used to treat diseases such as sclerosis, hepatitis, eczema, dysentery diarrhea, hemorrhoids, malignant boils, and burns. When applied to a boil, it has a great effect in sucking out pus. also. Apply it to wounds bitten by insects or poisonous snakes as an antidote. Recently, various studies have shown that it has anti-cancer properties.
바위솔을 토종 및 약용 허브에 포함하고 있으며, 다양한 약리작용을 나타내 는 기능성 성분들이 다양하게 함유되어 있고, 이러한 성분은 단독으로 작용하기도 하고 함유된 성분들의 상호작용에 의해 약리작용을 통한 효능이 나타나게 된다. 기 존 연구들에 의하면 바위솔에는 기능성 성분 중 플라보노이드(flavonoid) 계열, 폴 리페놀(polyphenol) 계열들이 많이 함유되어 있다. 이들의 주작용은 항산화효과가 뛰어나다고 보고되었다(식이성 고지혈증 연구(원광대학교 약학대학, 정현주, 2009), 바위솔 부위별 추출물의 항균활성연구(부경대학교, 식품공학과, 안동현, 2009), 바위솔의 HL60 백혈병세포의 세포자멸사 유도효과(우석대학교 식품공학과, 오찬호, 2009), 생약재와 바위솔의 복합물에서 당뇨 혈당강하 효과(경상대학교, 성 낙주, 2013), 인체 전립선 암세포의 항암 효과(순천대학교, 식품영양학과, 서권일, 2014) 등의 연구들이 수행되었다).Rock pine is included among native and medicinal herbs, and contains a variety of functional ingredients that exhibit various pharmacological effects. These ingredients may act alone, or the efficacy through pharmacological action appears through the interaction of the contained ingredients. . According to existing studies, Baeksol contains a lot of flavonoids and polyphenols among the functional ingredients. It has been reported that their main action is excellent antioxidant effect (study on dietary hyperlipidemia (Wonkwang University College of Pharmacy, Hyeon-joo Jeong, 2009), study on antibacterial activity of extracts from different parts of Rock Pine (Pukyong National University, Department of Food Engineering, Dong-hyeon Ahn, 2009), Apoptosis-inducing effect on HL60 leukemia cells (Woosuk University, Department of Food Science and Technology, Oh Chan-ho, 2009), diabetic blood sugar-lowering effect from a complex of herbal medicine and rock sol (Gyeongsang National University, Seong Nakju, 2013), anticancer effect on human prostate cancer cells (Sunchon National University, Food) Studies have been conducted in the Department of Nutrition, Seo Kwon-il, 2014).
상술한 바와 같은 바위솔을 이용한 화장품 관련 특허로는 대한민국 특허 출 원 제10-2015-0169277호 “바위솔, 삼백초, 및 더위지기 추출물을 포함하는 주름 개선 및 피부손상 회복 촉진용 조성물” 및 대한민국 특허 출원 제10-2015-0058271 호 “바위솔 및 삼백초 추출물을 포함하는 주름 개선 및 피부손상 회복 촉진용 조 성물”이 공개되어 있는데, 그 내용은 바위솔 추출물, 삼백초 추출물, 더위지기 추 출물을 포함하는 주름의 예방 또는 개선용 화장용 조성물, 및 피부손상의 예방 또 는 회복 촉진용 화장용 내지 건강식품용 조성물에 관한 것이다.Patents related to cosmetics using rock brush as described above include Korean Patent Application No. 10-2015-0169277, “Composition for improving wrinkles and promoting skin damage recovery containing rock brush, trillium chinensis, and hot weather extract” and Korea Patent Application No. 10-2015-0169277 No. 10-2015-0058271, “A composition for improving wrinkles and promoting skin damage recovery containing extracts of Rock pine and Trifolium vulgaris,” is disclosed, and the contents include prevention of wrinkles or extracts of turmeric extract, and extracts of turmeric extract. It relates to cosmetic compositions for improvement, and cosmetic or health food compositions for preventing or promoting skin damage.
상술한 바와 같은 바위솔 추출물을 포함하고 있는 화장품 조성물은 바위솔 추출물의 기능성을 향상시키기 위하여 삼백초 내지 더위지기 추출물을 더 보강하여 구성되어 있으나, 이와 같은 복합 추출물을 사용하는 제조 공정이 복잡하고 화장품 조성물의 안정성에 문제가 발생할 수 있다.Cosmetic compositions containing the above-mentioned Baeksol extract are composed by further enhancing the functionality of the Bamangospermia extract and the extracts of Trifolium vulgaris or Daewigi extract. However, the manufacturing process using such complex extracts is complicated and the stability of the cosmetic composition is complicated. Problems may arise.
따라서, 본 발명은 상기 사정을 감안하여 발명한 것으로, 종래의 바위솔 추출물과 비교하여 피부 미백, 보습, 탄력 및 피부 재생 등의 효과가 증진된 바위솔 추출물을 통해 효과가 현저하게 향상된 화장품 조성물을 제공하고자 함에 목적이 있다. Accordingly, the present invention was invented in consideration of the above circumstances, and aims to provide a cosmetic composition with significantly improved effects through a Bavarian pine extract, which has improved effects such as skin whitening, moisturizing, elasticity, and skin regeneration compared to a conventional Baja pine extract. There is a purpose.
상기 기술적 과제를 달성하기 위하여, 본 발명은 바위솔 모종을 식재하고, 키토산올리고당을 1:100 ~ 1:1,000의 중량비로 물에 희석한 후 수일 간격으로 엽면시비하여 재배 및 수확하고, 수확한 바위솔을 추출한 바위솔 추출물을 유효성분으로 함유하는 것을 특징으로 한다. In order to achieve the above technical problem, the present invention is to plant rock brush seedlings, dilute chitosan oligosaccharide in water at a weight ratio of 1:100 to 1:1,000, cultivate and harvest by foliar application at intervals of several days, and harvest the rock brush. It is characterized by containing extracted rock pine extract as an active ingredient.
또한, 상기 수확한 바위솔은 꽃대 출수 전기에 수확한 것을 특징으로 한다. In addition, the harvested rock brush is characterized in that it is harvested before flower stalks emerge.
또한, 상기 바위솔 추출물은 추출 용매가 물 또는 에탄올인 것을 특징으로 한다. In addition, the rock pine extract is characterized in that the extraction solvent is water or ethanol.
또한, 상기 바위솔 추출물은 추출 용매가 50~70℃로 가온한 에탄올인 것을 특징으로 한다. In addition, the above-mentioned rock pine extract is characterized in that the extraction solvent is ethanol heated to 50-70°C.
본 발명의 다른 실시예에 따른 화장품 조성물 제조 방법은, 바위솔 모종을 식재하는 단계; 상기 바위솔 모종에 키토산올리고당을 1:100 ~ 1:1,000의 중량비로 물에 희석한 후 수일 간격으로 엽면시비하는 단계; 재배한 바위솔을 수확하는 단계; 수확한 바위솔을 이용하여 바위솔 추출물을 얻는 단계; 상기 바위솔 추출물을 포함하는 화장품 조성물을 제조하는 단계; 를 포함한다. A method for manufacturing a cosmetic composition according to another embodiment of the present invention includes planting rock brush seedlings; Diluting chitosan oligosaccharide in water at a weight ratio of 1:100 to 1:1,000 to the rock brush seedlings and then fertilizing the leaves at intervals of several days; Harvesting the cultivated rock brush; Obtaining rock brush extract using harvested rock brush; Preparing a cosmetic composition containing the rock pine extract; Includes.
또한, 상기 바위솔을 수확하는 단계에서는 바위솔의 꽃대 출수 전기에 수확하는 것을 특징으로 한다. In addition, the step of harvesting the rock brush is characterized in that it is harvested before the flower stalks of the rock brush emerge.
본 발명에 따른 화장품 조성물은 종래의 바위솔 추출물보다 효과가 향상된 추출물을 유효성분으로 함유하여 피부 미백, 피부 각질의 보습, 탄력, 재생을 촉진하여 촉촉함의 유지 및 당김, 건조 등을 해소하고 피부 미백 및 탄력을 증대시키는 효과가 있어 항노화 화장품 조성물로서 매우 적합 유용하게 사용될 수 있다. The cosmetic composition according to the present invention contains as an active ingredient an extract with improved effectiveness compared to the conventional Rock pine extract, and promotes skin whitening, moisturizing, elasticity, and regeneration of the skin's dead skin cells, maintaining moisture, relieving tightness, dryness, etc., and improving skin whitening and It has the effect of increasing elasticity, so it can be very suitable and useful as an anti-aging cosmetic composition.
이하 첨부한 도면을 참조하여 본 발명의 바람직한 실시예에 대한 구성 및 작용을 상세히 설명하면 다음과 같다. 여기서 각 도면의 구성요소들에 대해 참조부호를 부가함에 있어서 동일한 구성요소들에 한해서는 비록 다른 도면상에 표시되더라도 가능한 한 동일한 부호로 표기되었음에 유의하여야 한다.Hereinafter, the structure and operation of a preferred embodiment of the present invention will be described in detail with reference to the attached drawings. Here, in adding reference numerals to components in each drawing, it should be noted that identical components are indicated with the same reference numerals as much as possible, even if they are shown in different drawings.
본 발명의 발명자는 바위솔 모종을 식재하고, 키토산올리고당(키토올리고당)을 1:100 ~ 1:1,000의 중량비로 물에 희석한 후 수일 간격, 바람직하게는 10~20일(예를 들어, 15일) 간격으로 엽면시비하여 바위솔 유기농 재배를 완성할 수 있었다. 엽면시비란 액체 비료를 식물의 잎에 직접 공급하는 방법을 말한다. 키토산은 갑각류(게, 새우 등)의 껍질, 연체류(오징어, 갑오징어 등)의 뼈를 분쇄, 탈단백, 탈염화한 키틴을 탈아세틸화하여 얻어지며, 이 키토산을 효소 처리하여 당의 수가 2~10개인 것을 얻어낸 것이 키토산올리고당이다.The inventor of the present invention plants rock brush seedlings, dilutes chitosan oligosaccharides (chitooligosaccharides) in water at a weight ratio of 1:100 to 1:1,000, and then plants them at intervals of several days, preferably 10 to 20 days (for example, 15 days). ) Organic cultivation of rock pine was able to be completed by foliar application at intervals. Foliar fertilization refers to a method of supplying liquid fertilizer directly to the leaves of plants. Chitosan is obtained by deacetylating the shells of crustaceans (crabs, shrimp, etc.) and the bones of molluscs (squid, cuttlefish, etc.) by pulverizing, deproteinizing, and desalting chitin. This chitosan is treated with enzymes to reduce the number of sugars from 2 to 2. The 10 obtained were chitosan oligosaccharides.
이러한 재배방법으로 생산된 바위솔을 추출하여 바위솔 추출물을 제조하고, 이러한 바위솔 추출물을 이용하여 화장품 조성물을 제조하는 경우, 종래의 일반 재배에 의한 바위솔 추출물을 사용할 때보다 피부 미백, 보습, 탄력 및 피부 재생 등의 효과가 증진되는 것을 확인하여 본 발명을 완성하였다.When rock pine extract produced by this cultivation method is extracted and cosmetic compositions are manufactured using the rock pine extract, skin whitening, moisturizing, elasticity, and skin regeneration are achieved more than when using rock pine extract produced through conventional cultivation. The present invention was completed by confirming that such effects were improved.
상기 화장품 조성물 제조 방법에서는, 바위솔 모종을 식재하는 단계; 상기 바위솔 모종에 키토산올리고당을 1:100 ~ 1:1,000의 중량비로 물에 희석한 후 수일 간격으로 엽면시비하는 단계; 재배한 바위솔을 수확하는 단계; 수확한 바위솔을 이용하여 바위솔 추출물을 얻는 단계; 상기 바위솔 추출물을 포함하는 화장품 조성물을 제조하는 단계; 를 포함한다. In the cosmetic composition manufacturing method, planting rock brush seedlings; Diluting chitosan oligosaccharide in water at a weight ratio of 1:100 to 1:1,000 to the rock brush seedlings and then fertilizing the leaves at intervals of several days; Harvesting the cultivated rock brush; Obtaining rock brush extract using harvested rock brush; Preparing a cosmetic composition containing the rock pine extract; Includes.
또한, 바위솔 모종을 재배하면서 꽃대 출수 전기와 후기로 나누어 수확한 후에 바위솔 추출물을 제조하여 피부 미백, 보습, 탄력 및 피부 재생 등의 효과를 확인하였고, 꽃대 출수 전기의 바위솔 추출물에서 더욱 향상된 피부 미백, 보습, 탄력 및 피부 재생 등의 효과를 확인할 수 있었다. 바람직하게는, 키토산올리고당을 물에 희석하여 엽면시비를 통해 유기농 재배를 하고, 바위솔의 꽃대 출수 전기에 수확하여 추출한 추출물을 유효성분으로 포함하는 화장품 조성물을 제공한다. 바위솔의 꽃대 출수 전에는 수분을 많이 포함하고 있어서 피부 보습이나 진정효과가 뛰어난 것으로 판단된다. 바위솔의 꽃대 출수 후에는 황산화 물질인 폴리페놀과 프라보노이드 계통이 더 많이 나온다.In addition, while cultivating rock pine seedlings, they were harvested in the early and late stages of flower stalk emergence, and then an extract of rock pine was prepared to confirm the effects of skin whitening, moisturizing, elasticity, and skin regeneration, and the skin whitening and skin regeneration benefits were further improved from the rock pine extract in the early stage of flower stalk emergence. Effects such as moisturizing, elasticity, and skin regeneration were confirmed. Preferably, chitosan oligosaccharides are diluted in water and grown organically through foliar fertilization, and a cosmetic composition is provided that includes an extract extracted by harvesting the flower stalks of the rock brush before emergence as an active ingredient. The flower stalks of the rock pine contain a lot of moisture before sprouting, so it is believed to have excellent skin moisturizing and soothing effects. After the flower stalks of the rock brush are sprouted, more polyphenols and flavonoids, which are sulfated substances, are released.
본 발명에 따른 바위솔 추출물에서 추출방법은 기술 분야에 알려진 것이라면 특별한 제한이 없으며, 바람직하게는 물 또는 에탄올을 추출 용매로 하여 추출한다. 수확한 바위솔을 물로 추출하는 경우 냉침부터 열수 추출까지 모두 이용할 수 있으며, 에탄올로 추출하는 경우에도 다양한 에탄올 농도, 온도 및 압력 조건에서 추출되는 것을 모두 이용할 수 있다.The extraction method from the rock pine extract according to the present invention is not particularly limited as long as it is known in the art, and is preferably extracted using water or ethanol as an extraction solvent. When extracting harvested rock pine with water, everything from cold immersion to hot water extraction can be used, and when extracting with ethanol, all extractions under various ethanol concentration, temperature, and pressure conditions can be used.
본 발명에 따른 바위솔 추출물의 예를 들면 다음과 같다.Examples of the rock pine extract according to the present invention are as follows.
(a) 유기농 바위솔을 시기별로 수확하여 세척하고 (b) 생체 중량부에 따라 물을 넣고 물(25~100℃)로 추출하거나, 생체 중량부에 에탄올을 가하여 실온(25℃) 또는 가온(50~70℃)에서 5~72시간 동안 추출하는 단계; 및 (c) 추출액을 직접 또 는 에탄올 증발 후 장기 보관하는 단계를 포함한다.(a) Organic rock brush is harvested and washed by season, and (b) water is added according to the live weight and extracted with water (25~100℃), or ethanol is added to the live weight and heated to room temperature (25℃) or warmed (50℃). Extracting at ~70°C for 5-72 hours; and (c) long-term storage of the extract directly or after evaporation with ethanol.
상술한 바와 같은 본 발명의 화장품 조성물은 화장품 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 일 예로 항산화제, 안정화제, 용해화제, 비 타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The cosmetic composition of the present invention as described above may contain ingredients commonly used in cosmetic compositions, for example, conventional auxiliaries such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, and carriers. Includes.
이와 같은 화장품 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으 로도 제조될 수 있다. 일 예로 고점도 유화제형, 저점도 유화제형 및 가용화 제형으로 이루어진 군에서 선택된 어느 하나의 제형일 수 있으나, 이에 제한되는 것은 아니다. Such cosmetic compositions can be prepared in any formulation commonly prepared in the art. For example, it may be any one formulation selected from the group consisting of high viscosity emulsion formulation, low viscosity emulsion formulation, and solubilization formulation, but is not limited thereto.
제조하고자 하는 제형에 따라 발명이 속하는 기술 분야에서 통상적으로 사용되는 화장품 조성물 배합 성분을 포함할 수 있다. 일 예로 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 팩, 마사지크림 및 스프레 이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 선로션, 선크림, 메이크업 베이스, 비비크림, 클렌징크림, 클렌징폼, 클렌징 워터, 팩, 스틱 상 제품, 밤(Balm) 타입 제품, 스프레이 또는 파우더의 제형으로 제조될 수 있다.Depending on the formulation to be manufactured, it may contain cosmetic composition ingredients commonly used in the technical field to which the invention pertains. For example, it is formulated as a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, pack, massage cream, and spray. It may be possible, but it is not limited to this. More specifically, flexible lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, sun lotion, sunscreen, makeup base, BB cream, cleansing cream, cleansing foam, cleansing water, pack, stick product, balm ( It can be manufactured as a balm type product, spray or powder formulation.
제조하고자 하는 제형에 따라 추가로 수상성분, 유상성분, 계면활성제, 보습 제, 저급알콜, 점증제, 킬레이트제, 방부제, 향료 등을 선택하여 배합 첨가할 수 있다.Depending on the formulation to be manufactured, additional water-phase components, oil-phase components, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, preservatives, fragrances, etc. can be selected and added.
이하, 실시예 및 실험예를 통하여 본 발명을 상세하게 설명하기로 한다. 상 술한 실시예의 기술에 의해 본 발명이 제한되는 것이 아님은 명백하다.Hereinafter, the present invention will be described in detail through examples and experimental examples. It is clear that the present invention is not limited by the description of the above-described embodiments.
[실시예][Example]
다음과 같은 바위솔 추출물을 제조하여 후술하는 시험에 사용하였다.The following rock pine extract was prepared and used in the test described later.
실시예 1: 키토산올리고당 엽면시비, 꽃대 출수 전, 냉침법에 의한 물 추 출(30℃, 30시간)Example 1: Chitosan oligosaccharide foliar application, before flower stalk extraction, water extraction by cold steeping method (30°C, 30 hours)
실시예 2: 키토산올리고당 엽면시비, 꽃대 출수 전, 열수 추출(100℃, 10시간)Example 2: Chitosan oligosaccharide foliar application, before flower stalk emergence, hot water extraction (100°C, 10 hours)
실시예 3: 키토산올리고당 엽면시비, 꽃대 출수 전, 70중량% 에탄올 상온 추출(30℃, 20시간)Example 3: Chitosan oligosaccharide foliar application, before flower stalk emergence, 70% by weight ethanol room temperature extraction (30°C, 20 hours)
실시예 4: 키토산올리고당 엽면시비, 꽃대 출수 전, 70중량% 에탄올 가온 추출(60℃, 10시간)Example 4: Chitosan oligosaccharide foliar application, before flower stalk emergence, extraction with 70% by weight ethanol heating (60°C, 10 hours)
실시예 5: 키토산올리고당 엽면시비, 꽃대 출수 후, 냉침법에 의한 물 추 출(30℃, 30시간)Example 5: Chitosan oligosaccharide foliar application, flower stalk extraction, and water extraction by cold immersion method (30°C, 30 hours)
실시예 6: 키토산올리고당 엽면시비, 꽃대 출수 후, 열수 추출(100℃, 10시간)Example 6: Chitosan oligosaccharide foliar application, flower stalk extraction, hot water extraction (100°C, 10 hours)
실시예 7: 키토산올리고당 엽면시비, 꽃대 출수 후, 70중량% 에탄올 상온 추출(30℃, 20시간)Example 7: Chitosan oligosaccharide foliar application, flower stalk extraction, 70% by weight ethanol room temperature extraction (30°C, 20 hours)
실시예 8: 키토산올리고당 엽면시비, 꽃대 출수 후, 70중량% 에탄올 가온 추출(60℃, 10시간)Example 8: Chitosan oligosaccharide foliar application, flower stalk extraction, 70% by weight ethanol heating extraction (60°C, 10 hours)
또한, 비교예 1 내지 8은 실시예 각각과 동일하였으나, 다만 키토산올리고당 엽면시비를 하지 않는 것에 차이가 있다.In addition, Comparative Examples 1 to 8 were the same as each of the Examples, except that foliar application of chitosan oligosaccharide was not applied.
[시험예][Test example]
1. Elastase 저해율 측정1. Elastase inhibition rate measurement
엘라스틴(Elastin)을 분해하는 효소인 엘라스테이즈(Elastase)의 활성 저해 효과를 다음과 같이 확인하였다.The effect of inhibiting the activity of Elastase, an enzyme that decomposes elastin, was confirmed as follows.
엘라스테이즈(Elastase)는 사람의 백혈구 세포로부터 유래한 엘라스테이즈를 사용하였고, 엘라스테이즈의 기질로 합성 기질인 MeOSuc-Ala-Ala-Pro-Val-pNA를 사 용하였다. 완충용액은 100mM의 Tris(pH 7.5) 용액을 사용하였다. 엘라스테이즈는 완충용액을 이용하여 최종적으로 0.2mU을 사용하였다. 또한, 엘라스테이즈의 합성 기질은 DMSO를 이용하여 100mM 용액을 만든 후 최종 농도가 0.5mM이 되도록 완충용 액을 이용하여 희석하였다.Elastase derived from human white blood cells was used, and the synthetic substrate MeOSuc-Ala-Ala-Pro-Val-pNA was used as the elastase substrate. A 100mM Tris (pH 7.5) solution was used as the buffer solution. Elastase was used in a final amount of 0.2mU using a buffer solution. In addition, the synthetic substrate of elastase was made into a 100mM solution using DMSO and then diluted using a buffer solution to reach a final concentration of 0.5mM.
이때, 양성 대조군은 엘라스테이즈 저해 물질로 알려진 퀘르세틴(Quercetin) 을 사용하였다. 반응은 96-웰플레이트에서 진행하였으며, 상온에서 20분간 반응시 켰다. 분광 광도계를 이용하여 1분 간격으로 405nm에서 흡광도를 측정하여 시간 대비 흡광도의 기울기를 구하여 효소의 활성도로 정하였다. 엘라스테이즈 저해율은 다음과 같이 계산하여 그 결과를 표 1에 나타냈다.At this time, quercetin, known as an elastase inhibitor, was used as a positive control. The reaction was carried out in a 96-well plate and reacted at room temperature for 20 minutes. Absorbance was measured at 405 nm at 1-minute intervals using a spectrophotometer, and the slope of absorbance versus time was determined to be the enzyme activity. The elastase inhibition rate was calculated as follows and the results are shown in Table 1.
상기 표 1을 보면, 본 발명에 따른 실시예에서는 모두 양성 대조군보다 모두 향상된 저해율을 보였으며, 또한 꽃대 출수 전에 출수 후보다 향상된 결과를, 물보 다는 에탄올에서, 상온보다는 가온하는 경우 우수한 저해율을 보였다.Looking at Table 1, the examples according to the present invention all showed improved inhibition rates compared to the positive control group, and also showed improved results before and after flower stalk sprouting, superior inhibition rates when used in ethanol rather than water, and when heated rather than at room temperature.
본 발명의 실시예와 대비하여 키토산올리고당 엽면시비를 하지 않은 비교예 에서는 양성대조군보다 낮은 결과를 보였고, 본 발명의 실시예와는 현저하게 차이가 있는 결과를 보였다.Compared to the examples of the present invention, the comparative examples without foliar application of chitosan oligosaccharide showed lower results than the positive control group and showed significantly different results from the examples of the present invention.
2. Collagenase 저해율 측정2. Collagenase inhibition rate measurement
콜라겐(Collagen)을 분해하는 효소인 콜라게나제의 활성 저해 효과를 다음과 같이 확인하였다.The effect of inhibiting the activity of collagenase, an enzyme that decomposes collagen, was confirmed as follows.
콜라게나제는 쥐의 이자에서 유래한 콜라게나제를 사용하였고, 콜라게나제의 기질로 합성 기질인 N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala을 사용하였다. 완충 용액은 50mM Tricine, 10mM CaCl2·H2O, 400mM NaCl(pH7.5)이 녹아 있는 용액을 사 용하였다. 합성 기질은 완충용액을 이용하여 10mM의 농도로 녹인 후 최종적으로 75 μM이 되도록 희석하였다. 콜라게나제는 4도의 차가운 3차 증류수를 이용하여 1unit/ml 농도로 녹인 후 최종적으로 0.05unit/ml이 되도록 완충용액을 이용하여 희석하였다.Collagenase derived from rat pancreas was used, and the synthetic substrate N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala was used as the collagenase substrate. The buffer solution was a solution containing 50mM Tricine, 10mM CaCl 2 ·H 2 O, and 400mM NaCl (pH 7.5). The synthetic substrate was dissolved to a concentration of 10mM using a buffer solution and then diluted to a final concentration of 75 μM. Collagenase was dissolved at a concentration of 1 unit/ml using cold 4-degree distilled water and then diluted with a buffer solution to a final concentration of 0.05 unit/ml.
양성 대조군은 콜라게나제 저해 효과가 알려진 에피갈로카테킨 갈레이 트(EGCG)를 사용하였으며, 반응은 96-웰플레이트에서 진행하였으며, 상온에서 10분 간 반응시켰다. 분광 광도계를 이용하여 1분 간격으로 345 nm에서 흡광도를 측정하 여 시간 대비 흡광도의 최대 기울기를 구하여 효소의 활성으로 정하였다. 콜라게나 제 저해율은 다음과 같이 계산하여 그 결과를 표 2에 나타냈다.Epigallocatechin gallate (EGCG), which is known to have a collagenase inhibitory effect, was used as a positive control, and the reaction was carried out in a 96-well plate and reacted at room temperature for 10 minutes. Absorbance was measured at 345 nm at 1-minute intervals using a spectrophotometer, and the maximum slope of absorbance versus time was determined to be the enzyme activity. The collagenase inhibition rate was calculated as follows and the results are shown in Table 2.
상기 표 2를 보면, 본 발명에 따른 실시예에서는 모두 양성 대조군보다 모두 향상된 저해율을 보였으며, 또한 꽃대 출수 전에 출수 후보다 향상된 결과를, 물보 다는 에탄올에서, 상온보다는 가온하는 경우 우수한 저해율을 보였다.Looking at Table 2, the examples according to the present invention all showed improved inhibition rates compared to the positive control group, and also showed improved results before and after flower stalk sprouting, superior inhibition rates when used in ethanol rather than water, and when heated rather than at room temperature.
본 발명의 실시예와 대비하여 키토산올리고당 엽면시비를 하지 않은 비교예 에서는 양성대조군보다 낮은 결과를 보였고, 본 발명의 실시예와는 현저하게 차이가 있는 결과를 보였다.Compared to the examples of the present invention, the comparative examples without foliar application of chitosan oligosaccharide showed lower results than the positive control group and showed significantly different results from the examples of the present invention.
3. 세포증식 효과 측정3. Measurement of cell proliferation effect
피부세포 증식 활성화에 대하여 확인하기 위해, 사람의 섬유아세포를 사용하 여 세포증식 활성능을 측정하였다.To confirm the activation of skin cell proliferation, the cell proliferation activity was measured using human fibroblasts.
실시예 및 비교예의 시료를 배양액에 첨가한 후, 사람의 섬유아세포를 배양 하여 MTT 환원법을 수행하고, 포르마잔(formazan) 생성물을 이소프로필 알코올로 추출하여, 570nm에서 흡광도를 측정함으로써 세포증식 활성능을 상대비교하였다. 이때, 음성대조군으로는 시료는 넣지 않은 배양액을 사용하였다. 측정한 결과를 하 기 식을 이용하여 수치로 계산하였다.After adding the samples of Examples and Comparative Examples to the culture medium, human fibroblasts were cultured, MTT reduction was performed, the formazan product was extracted with isopropyl alcohol, and the absorbance was measured at 570 nm to determine cell proliferation activity. were compared. At this time, culture medium without samples was used as a negative control. The measured results were calculated numerically using the following formula.
세포증식능(%) = 각 시료군에서의 흡광도/대조군에서의 흡광도Cell proliferation ability (%) = absorbance in each sample group/absorbance in control group
상기 표 3을 보면, 대조군의 세포증식 활성능(100%)에 비하여 본 발명의 실시예 및 비교예 모두 100% 이상을 보였으나, 본 발명의 실시예가 비교예보다 현저하게 상승된 결과를 보였다.Looking at Table 3, both the examples and comparative examples of the present invention showed more than 100% of the cell proliferation activity (100%) of the control group, but the examples of the present invention showed significantly higher results than the comparative examples.
또한, 본 발명에 따른 실시예에서는 꽃대 출수 전에 출수 후보다 향상된 결 과를, 물보다는 에탄올에서, 상온보다는 가온하는 경우 우수한 활성능을 보였다.In addition, in the examples according to the present invention, improved results were shown before the flower stalks were picked compared to after they were picked, and excellent activity was shown when the flower stalks were heated in ethanol rather than water and at a temperature higher than room temperature.
4. 인체 적용시 수분 보유능의 평가4. Evaluation of water retention capacity when applied to the human body
실시예 및 비교예의 조성물에 대한 피부 보습 효과를 평가하기 위하여, 실시예와 비교예의 물질이 도포된 피부를 대상으로 수분 보유능을 다음과 같이 측정하였다.In order to evaluate the skin moisturizing effect of the compositions of Examples and Comparative Examples, the water retention capacity was measured on the skin to which the materials of Examples and Comparative Examples were applied as follows.
수분 보유능의 측정은 실내온도 22℃ 및 상대습도 45%의 항온 항습실에서 20 명의 피시험자 전박 안쪽에 일정량(0.1g/4㎠)을 도포하고, 도포 전, 도포 1시간 후 및 도포 2시간 후의 피부의 수분 함량을 측정하였다. 측정 기기는 피부의 수분 함 량에 따른 피부의 전기 용량을 측정하여 보습력을 측정하는 수분 함량측정 기(corneometer CM820, Courage + Khazaka, Cologne, 독일)를 사용하였고, 그 결과는 하기 표 4에 나타내었다.To measure water retention capacity, a certain amount (0.1g/4㎠) was applied to the inside of the forearm of 20 test subjects in a constant temperature and humidity room with an room temperature of 22℃ and a relative humidity of 45%, and the skin was measured before application, 1 hour after application, and 2 hours after application. The moisture content was measured. The measuring device used was a moisture content meter (corneometer CM820, Courage + Khazaka, Cologne, Germany), which measures the moisturizing power by measuring the electrical capacitance of the skin according to the moisture content of the skin, and the results are shown in Table 4 below. .
상기 표 4로부터 본 발명에 따른 조성물이 비교예의 조성물에 비하여 현저하 게 우수한 수분 보유능이 있음을 확인할 수 있었고, 이는 매우 뛰어난 보습효과를 갖는 소재임을 입증한 것이다.From Table 4 above, it was confirmed that the composition according to the present invention had a significantly superior moisture retention ability compared to the composition of the comparative example, which proved that it was a material with an excellent moisturizing effect.
또한, 본 발명에 따른 실시예에서는 꽃대 출수 전에 출수 후보다 향상된 결 과를, 물보다는 에탄올에서, 상온보다는 가온하는 경우 우수한 활성능을 보였다.In addition, in the examples according to the present invention, improved results were shown before the flower stalks were picked compared to after they were picked, and excellent activity was shown when the flower stalks were heated in ethanol rather than water and at a temperature higher than room temperature.
5. 피부 미백: 멜라닌 생성 저해 효과 확인5. Skin whitening: Check the effect of inhibiting melanin production
실시예와 비교예의 조성물을 쥐의 멜라노마 세포(B-16 mouse melanoma cell) 의 배양액에 첨가하여 세포 수준에서의 미백효과를 실험하였다. (Lotan R, Lotan D Cancer Res 40:3345-3350, 1980)The compositions of Examples and Comparative Examples were added to the culture medium of B-16 mouse melanoma cells, and the whitening effect at the cellular level was tested. (Lotan R, Lotan D Cancer Res 40:3345-3350, 1980)
실험 전 쥐의 멜라노마 세포에 대하여 독성을 평가하여 독성이 없는 농도를 선정하여 미백평가를 수행하였다.Before the experiment, toxicity was evaluated for rat melanoma cells, a non-toxic concentration was selected, and whitening evaluation was performed.
최종농도는 100㎍/ml가 되도록 하여 실험하였으며, 대조군인 알부틴은 100㎍/ml가 되도록 배지에 첨가하여 각각 B-16멜라노마 세포에 처리하여 3일간 배양하였 다.The final concentration was tested to be 100㎍/ml, and arbutin as a control was added to the medium to be 100㎍/ml, treated with B-16 melanoma cells, and cultured for 3 days.
이후, 세포들을 트립신(trypsin) 처리하여 배양용기로부터 떼어내 원심분리 한 후 멜라닌을 추출하였다. 떼어낸 세포는 수산화 나트륨 용액(1N농도) 1ml를 가 하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용하여, 400나노미터(nm)에서 흡광도를 측정하여 생성된 멜라닌의 양을 측정하였다.Afterwards, the cells were treated with trypsin, removed from the culture vessel, centrifuged, and melanin was extracted. 1 ml of sodium hydroxide solution (1N concentration) was added to the removed cells and boiled for 10 minutes to dissolve the melanin. The amount of melanin produced was measured by measuring the absorbance at 400 nanometers (nm) using a spectrophotometer.
상기 멜라닌 양은 단위 세포수당(106cell)의 흡광도로 나타내는 방법으로 측 정하였으며, 대조군에 대한 상대적인 멜라닌 생성량을 저해율(%)로 계산하고 결과 를 표 4에 정리하였다. 또한, 실험은 3번 반복된 것이다.The amount of melanin was measured by expressing the absorbance per unit cell (10 6 cells), and the amount of melanin production relative to the control group was calculated as an inhibition rate (%), and the results are summarized in Table 4. Additionally, the experiment was repeated three times.
표 5의 결과에서 볼 수 있듯이, 본 발명의 조성물은 기존에 알려진 미백 물 질인 알부틴과 비교할 때 배양된 쥐의 멜라노마 세포에 대하여 월등히 우수한 멜라 닌 생성 억제능이 있음을 알 수 있었으며, 이와 대비하여 비교예의 경우에는 본 발 명보다 현저하게 저해된 멜라닌 생성 억제능을 보였다.As can be seen from the results in Table 5, the composition of the present invention was found to have a significantly superior melanin production inhibition ability against cultured rat melanoma cells compared to arbutin, a previously known whitening substance, and compared with this. In the case of the example, the ability to inhibit melanin production was significantly inhibited compared to that of the present invention.
또한, 본 발명에 따른 실시예에서는 꽃대 출수 전에 출수 후보다 향상된 결 과를, 물보다는 에탄올에서, 상온보다는 가온하는 경우 우수한 활성능을 보였다.In addition, in the examples according to the present invention, improved results were shown before the flower stalks were picked compared to after they were picked, and excellent activity was shown when the flower stalks were heated in ethanol rather than water and at a temperature higher than room temperature.
처방예: 투명 수분겔Prescription example: Transparent moisture gel
본 발명의 바위솔 추출물을 포함한 화장품 중 투명 수분겔의 처방예는 다음 과 같다(표 6 참조).Examples of formulations of transparent water gel among cosmetics containing the Bacon pine extract of the present invention are as follows (see Table 6).
여기에 들어가는 바위솔 추출액은 실시예 4에서 얻은 추출물이다.The rock pine extract used here is the extract obtained in Example 4.
투명수분겔(백리설빙화) 관능평가Sensory evaluation of transparent water gel (White Lisulbinghwa)
본 과제에서 만들어진 투명수분겔 관능평가 설문지를 다음 표 7과 같이 작 성하였으며, 아래의 표와 결과를 도출하였다.The sensory evaluation questionnaire for the transparent water gel created in this project was prepared as shown in Table 7 below, and the results were derived from the table below.
전북허브산학연협력단
신제품을 쓰는 귀하는 남성인가요? 여성인가요?
신제품을 쓰는 귀하의 나이연령은 어떻게 되나요?
신제품을 쓰는 귀하의 지역은 어디십니까?
1. 신제품의 디자인은 어떤가요 ?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
2. 신제품의 용기 사용은 편리한가요 ?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
3. 신제품의 디자인 색깔은 어떠신가요?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
4. 신제품의 발림성은 어떤가요 ?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
5. 신제품의 향은 어떤가요 ?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
6. 신제품의 제형은 어떤가요 ?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
7. 신제품의 촉감은 어떤가요 ?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
8. 신제품을 타사제품과 비교했을 때 차별성이 있나요?
① 매우 우수 ② 우수 ③ 보통 ④ 보통 이하 ⑤ 기대 이하
*매우 우수(5점), 우수(4점), 보통(3점), 보통 이하(2점), 기대 이하(1점)Transparent moisture gel (White Lisulbinghwa) cosmetics test questionnaire
Jeonbuk Hub Industry-Academy-Research Cooperation Foundation
Are you a man who writes new products? Are you a woman?
What is your age when using a new product?
Where are you working on new products?
1. How is the design of the new product?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
2. Is the new product’s container convenient to use?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
3. What do you think of the design colors of the new product?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
4. How is the application quality of the new product?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
5. What does the new product smell like?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
6. What is the formulation of the new product?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
7. How does the new product feel?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
8. Is there any differentiation between the new product and those of other companies?
① Very good ② Excellent ③ Average ④ Below average ⑤ Below expectations
*Very good (5 points), Excellent (4 points), Average (3 points), Below average (2 points), Below expectations (1 point)
관능평가 결과는 아래와 같다. 전반적으로 우수하다는 평가를 받았다.The sensory evaluation results are as follows. It was evaluated as excellent overall.
전체적으로 전문가로 구성된 관능평가 결과 3.66(5점 만점)점을 나타내어. 본 실시예에서 만들어진 투명 수분겔이 우수함을 입증하였다.Overall, the sensory evaluation conducted by experts gave a score of 3.66 (out of 5). The transparent water gel produced in this example was proven to be excellent.
이상에서 살펴 본 바와 같이, 본 발명에 따른 화장품 조성물은 종래의 바위 솔 추출물보다 효과가 향상된 추출물을 유효성분으로 함유하여 피부 미백, 피부 각질의 보습, 탄력, 재생을 촉진하여 촉촉함의 유지 및 당김, 건조 등을 해소하고, 피부 미백 및 탄력을 증대시키는 효과가 있어 항노화 화장품 조성물로 매우 적합 유용하게 사용될 수 있다.As seen above, the cosmetic composition according to the present invention contains as an active ingredient an extract with improved effectiveness compared to the conventional rock pine extract, and promotes skin whitening, moisturizing, elasticity, and regeneration of the skin's dead skin cells, thereby maintaining moisture and pulling, It has the effect of relieving dryness, whitening the skin, and increasing elasticity, so it can be very suitable and useful as an anti-aging cosmetic composition.
본 발명은 상기 실시예에 한정되지 않고 본 발명의 기술적 요지를 벗어나지 아니하는 범위 내에서 다양하게 수정 또는 변형되어 실시될 수 있음은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 있어서 자명한 것이다.It is obvious to those skilled in the art that the present invention is not limited to the above embodiments and can be implemented with various modifications or variations without departing from the technical gist of the present invention. will be.
Claims (6)
상기 수확한 바위솔은 꽃대 출수 전기에 수확한 것을 특징으로 하는 화장품 조성물.Planting rock pine seedlings, diluting chitosan oligosaccharides in water at a weight ratio of 1:100 to 1:1,000, cultivating and harvesting them by foliar application at intervals of several days, and containing rock pine extract extracted from the harvested rock pine as an active ingredient,
A cosmetic composition, characterized in that the harvested rock brush is harvested before flower stalks emerge.
상기 바위솔 추출물은 추출 용매가 물 또는 에탄올인 것을 특징으로 하는 화장품 조성물.According to paragraph 1,
A cosmetic composition wherein the extraction solvent for the rock pine extract is water or ethanol.
상기 바위솔 추출물은 추출 용매가 50~70℃로 가온한 에탄올인 것을 특징으로 하는 화장품 조성물.According to paragraph 3,
A cosmetic composition characterized in that the extraction solvent of the Bawisol extract is ethanol heated to 50-70°C.
바위솔 모종을 식재하는 단계;
상기 바위솔 모종에 키토산올리고당을 1:100 ~ 1:1,000의 중량비로 물에 희석한 후 수일 간격으로 엽면시비하는 단계;
재배한 바위솔을 수확하는 단계;
수확한 바위솔을 이용하여 바위솔 추출물을 얻는 단계;
상기 바위솔 추출물을 포함하는 화장품 조성물을 제조하는 단계;
를 포함하고,
상기 바위솔을 수확하는 단계에서는 바위솔의 꽃대 출수 전기에 수확하는 것을 특징으로 하는 화장품 조성물 제조 방법.In the method of manufacturing a cosmetic composition,
Planting rock brush seedlings;
Diluting chitosan oligosaccharide in water at a weight ratio of 1:100 to 1:1,000 to the rock brush seedlings and then fertilizing the leaves at intervals of several days;
Harvesting the cultivated rock brush;
Obtaining rock brush extract using harvested rock brush;
Preparing a cosmetic composition containing the rock pine extract;
Including,
A method of producing a cosmetic composition, characterized in that in the step of harvesting the rock brush, the flower stalk of the rock brush is harvested before emergence.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210064717A KR102596697B1 (en) | 2021-05-20 | 2021-05-20 | Cosmetic composition containing Orostachys japonicus extract as an active ingredient and method for manufacturing cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210064717A KR102596697B1 (en) | 2021-05-20 | 2021-05-20 | Cosmetic composition containing Orostachys japonicus extract as an active ingredient and method for manufacturing cosmetic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220158124A KR20220158124A (en) | 2022-11-30 |
KR102596697B1 true KR102596697B1 (en) | 2023-11-01 |
Family
ID=84234347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210064717A KR102596697B1 (en) | 2021-05-20 | 2021-05-20 | Cosmetic composition containing Orostachys japonicus extract as an active ingredient and method for manufacturing cosmetic composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102596697B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101925968B1 (en) * | 2016-01-29 | 2018-12-06 | 김현철 | Method for cultivating orostachys japonicus having bio minelal |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090101565A (en) * | 2008-03-24 | 2009-09-29 | 주식회사 건풍바이오 | The plant cultivating method by expediting the pentose phosphate pathway of plant metabolism |
CN104684556A (en) | 2012-09-18 | 2015-06-03 | 塔里斯生物医药公司 | Drug delivery systems and methods for treatment of bladder voiding dysfunction and other lower urinary tract disorders by using trospium |
KR101877510B1 (en) * | 2016-05-31 | 2018-07-11 | (주)월드코스텍 | Method for increasing production of orostachys japonicus and copposition containing extract of orostachys japonicus thereof |
-
2021
- 2021-05-20 KR KR1020210064717A patent/KR102596697B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101925968B1 (en) * | 2016-01-29 | 2018-12-06 | 김현철 | Method for cultivating orostachys japonicus having bio minelal |
Also Published As
Publication number | Publication date |
---|---|
KR20220158124A (en) | 2022-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101769416B1 (en) | Multifunctional mask composition and preparing method of the same including anti-wrinkles and whitening functions | |
KR101502687B1 (en) | Anti-aging and Anti-inflammatory and Anti-oxidant Cosmetic Composition including Beans Placenta Cell Cultures Extracts | |
KR101332214B1 (en) | Cosmetic composition for reducing skin stress comprising nelumbo nucifera flower extract, rice extract and artemisia annua extract | |
KR101100678B1 (en) | Cosmetic Composition comprising plant extracts | |
KR102167786B1 (en) | manufacturing method of fermented extract of Centella asiatica, Althaea rosea, Blue lotus, Swertia japonica Griseb using Lactobacillus and cosmetic composition using that fermented extract | |
KR100443588B1 (en) | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect | |
KR102004322B1 (en) | Cosmetic composition containing botanical extract complex | |
CN108186426B (en) | Antibacterial mask liquid, mask and preparation method of mask liquid | |
KR20120009554A (en) | Cosmetic composition comprising mixed herbal extracts having anti-oxidant activity and anti-allergic activity | |
KR101420211B1 (en) | Skin Composition for External Application Using Bud and Sprout Extract | |
KR100979143B1 (en) | Cosmetic composition containing herb extract for skin moisturizing effect and for enhancing skin elasticity | |
KR20170141564A (en) | Cosmetic composition containing propolis and extracts of opuntia humifusa | |
KR102596697B1 (en) | Cosmetic composition containing Orostachys japonicus extract as an active ingredient and method for manufacturing cosmetic composition | |
KR20110032715A (en) | Antiaging cosmetic compositions and method for producing thereof | |
KR102323174B1 (en) | Cosmetic composition for alleviating skin trouble | |
KR102400090B1 (en) | Cosmetic Composition for Reducing Skin Wrinkle | |
KR20160036834A (en) | Skin external application composition comprising complex fermented extract of crude drug ingredients | |
KR101574248B1 (en) | Cosmetic composition comprising Reynoutria sachalinensis extracts for skin anti-wrinkle effect | |
KR100946584B1 (en) | Cosmetic Composition Comprising Poncirus trifoliata fruit extract and Nymphaea caerulea extract | |
KR20100067700A (en) | Cosmetic compositions for skin care containing extract of tussilago farfara linne flower | |
KR20150136290A (en) | Extract Of bee venom, extract of willow bark and extract of fermented rice Containing Cosmetic Composition Having Anti-aging Effect | |
KR102470781B1 (en) | Cosmetic Composition for Reducing Skin Wrinkle | |
KR102233707B1 (en) | Cosmetic composition comprising natural extract and natural powder | |
KR100529542B1 (en) | Extraction method of a effective component of a cosmetic, composition of cosmetic and a cosmetic | |
KR102515900B1 (en) | Gel type face cleasing cosmetic and Manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |